{"id":"W3009161381","doi":"10.1200/jco.2007.25.18_suppl.7680","title":"Randomized phase II study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Interim analysis; Internal medicine; Toxicity; Adverse effect; Bortezomib; Oncology; Phases of clinical research; Surgery; Cancer; Clinical trial; Multiple myeloma; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003141307,0.001806882,0.004173893,0.0006180931,0.0005939476,0.001329931,0.001391469,0.002100792,0.007969426],"category_scores_gemma":[0.001971425,0.001191344,0.001361656,0.0006798718,0.001824135,0.001333651,0.0006096997,0.004104727,0.001736904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001017864,"about_ca_system_score_gemma":0.002141992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00104197,"about_ca_topic_score_gemma":0.002536468,"domain_scores_codex":[0.9990104,0.0005622749,0.00005693291,0.0001534839,0.00006754808,0.0001493251],"domain_scores_gemma":[0.9982448,0.0003840892,0.0002902254,0.0001807208,0.0001048853,0.000795302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9548431,0.02825458,0.0008194659,0.0002698219,0.000540993,0.00006798102,0.00007053636,0.0004831791,0.004565284,0.00008252199,0.0007834107,0.009219098],"study_design_scores_gemma":[0.8809754,0.1166367,0.001019856,0.000008423493,0.0001487811,0.00003682688,0.00001253948,0.0002963885,0.0003076683,0.00007443543,0.0004740204,0.000008968549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850545,0.001699847,0.0008797454,0.000686678,0.0005099319,0.008235619,0.001079671,0.0001403398,0.001713633],"genre_scores_gemma":[0.9757037,0.001878272,0.002614755,0.001550295,0.0005059332,0.01117501,0.001743271,0.00005148043,0.004777217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007969426,"threshold_uncertainty_score":0.02666044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03942949987271135,"score_gpt":0.4738325536847717,"score_spread":0.4344030538120603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}